Bell Investment Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4K | Sell |
35
-2
| -5% | -$652 | ﹤0.01% | 623 |
|
|
2025
Q1 | $9.99K | Buy |
37
+6
| +19% | +$1.62K | ﹤0.01% | 603 |
|
|
2024
Q4 | $7.3K | Sell |
31
-6
| -16% | -$1.41K | ﹤0.01% | 741 |
|
|
2024
Q3 | $10.2K | Buy |
37
+2
| +6% | +$550 | ﹤0.01% | 614 |
|
|
2024
Q2 | $8.51K | Sell |
35
-1
| -3% | -$243 | ﹤0.01% | 676 |
|
|
2024
Q1 | $5.38K | Buy |
36
+3
| +9% | +$448 | ﹤0.01% | 873 |
|
|
2023
Q4 | $6.32K | Sell |
33
-5
| -13% | -$957 | ﹤0.01% | 753 |
|
|
2023
Q3 | $6.73K | Hold |
38
| – | – | ﹤0.01% | 665 |
|
|
2023
Q2 | $7.22K | Hold |
38
| – | – | ﹤0.01% | 635 |
|
|
2023
Q1 | $7.61K | Sell |
38
-7
| -16% | -$1.4K | ﹤0.01% | 582 |
|
|
2022
Q4 | $10.7K | Sell |
45
-1
| -2% | -$238 | ﹤0.01% | 468 |
|
|
2022
Q3 | $9K | Buy |
46
+16
| +53% | +$3.13K | ﹤0.01% | 435 |
|
|
2022
Q2 | $4K | Buy |
+30
| New | +$4K | ﹤0.01% | 763 |
|
|
2021
Q4 | $3K | Sell |
18
-4
| -18% | -$667 | ﹤0.01% | 938 |
|
|
2021
Q3 | $4K | Buy |
+22
| New | +$4K | ﹤0.01% | 764 |
|